Answers are grounded in this paper and cite their sources.
A wide variety of conjugates containing RIPs, of either chemical or recombinant type, have been made and tested against dangerous cells in vitro and in animal models. Many of these pre-clinical studies will be reviewed here dividing them on the basis of the target cell and the surface molecule specifically recognized.
No takes yet. Share an insight, caveat, or question.
Bolognesi et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: